Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related INFI
Stifel Talks 5 Biotech Stocks
Deutsche Sees Cancer Treatment Home Run At Infinity Pharmaceuticals
Related CVD
KeyBanc Starts Lab Corp Of America At Overweight, But Indebtedness Is A Concern
Morgan Stanley Previews Earnings For Cardinal Health, Quest Diagnostics

Analysts at William Blair initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ: INFI) with a “market perform” rating. The target price for Infinity Pharmaceuticals is set to $21. Infinity's shares closed at $19.20 yesterday.

Credit Suisse initiated coverage on shares of Covance (NYSE: CVD) with an “outperform” rating. The target price for Covance is set to $101. Covance's shares closed at $85.02 yesterday.

Jefferies initiated coverage on shares of Church & Dwight Co (NYSE: CHD) with a “buy” rating. The target price for Church & Dwight is set to $72. Church & Dwight's stock closed at $61.78 yesterday.

Analysts at Morgan Stanley initiated coverage on shares of Booz Allen Hamilton Holding (NYSE: BAH) with an “equal-weight” rating. The target price for Booz Allen Hamilton is set to $21. Booz Allen Hamilton's shares closed at $19.38 yesterday.

Latest Ratings for INFI

DateFirmActionFromTo
May 2015Deutsche BankInitiates Coverage onBuy
Jan 2015Morgan StanleyDowngradesOverweightEqualweight
Dec 2014Credit SuisseUpgradesNeutralOutperform

View More Analyst Ratings for INFI
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (CHD + BAH)

Get Benzinga's Newsletters